A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence

Drug and Alcohol Dependence

Volumn 91, Issue 2-3, 2007, Pages 141-148

  Winhusen, Theresa ^a,b   Somoza, Eugene ^a,b,c   Ciraulo, Domenic A ^d   Harrer, Judy M ^a,c   Goldsmith, R Jeffrey ^a,c   Grabowski, John ^e   Coleman, Florence S ^c   Mindrum, Gordon ^b   Kahn, Roberta ^f   Osman, Sabuhi ^b   Mezinskis, Juris ^a,c   Li, Shou Hua ^f   Lewis, Daniel ^b   Horn, Paul ^b,c,g   Montgomery, Margaret A ^f   Elkashef, Ahmed ^f  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Cincinnati Addictions Research Center CinARC   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^g UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Clinical trial; Cocaine dependence; Double blind; Tiagabine

Indexed keywords

BENZOYLECGONINE; PLACEBO; TIAGABINE;

ADULT; AGED; ARTICLE; ASTHMA; BLURRED VISION; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DECREASED APPETITE; DETOXIFICATION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRUG USE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HEAD INJURY; HEADACHE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NAUSEA; NERVOUSNESS; OUTCOME ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SINUSITIS; SOMNOLENCE; STUPOR; SUICIDAL IDEATION; SWEATING; TACHYCARDIA; THORAX PAIN; VERTIGO; VITAL SIGN;

ADULT; ALCOHOLISM; COCAINE-RELATED DISORDERS; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROTRANSMITTER UPTAKE INHIBITORS; NIPECOTIC ACIDS; PLACEBOS; TREATMENT OUTCOME;

EID: 35048814919     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.05.028     Document Type: Article

References (25)

1. Adkins J.C., and Noble S. Tiagabine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy. Drugs 55 (1998) 437-460
2. Carroll K.M., Rounsaville B.J., Nich C., Gordon L.T., Wirtz P.W., and Gawin F.H. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch. Gen. Psychiatry 51 (1994) 989-997
3. Cone E.J. Pharmacokinetics and pharmacodynamics of cocaine. J. Anal. Toxicol. 19 6 (1995) 459-478
4. Cousins M.S., Roberts D.C., and de Wit H. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend. 65 (2002) 209-220
5. Campbell U.C., Lac S.T., and Carroll M.E. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 143 (1999) 209-214
6. Dewey S.L., Chaurasia C.S., Chen C.E., Volkow N.D., Clarkson F.A., Porter S.P., Straughter-Moore R.M., Alexoff D.L., Tedeschi D., Russo N.B., Fowler J.S., and Brodie J.D. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse 25 (1997) 350-356
7. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., and Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J. Consult. Clin. Psychol. 68 (2000) 134-144
8. González G., Desai R., Sofuoglu M., Poling J., Olivito A., Gonsai K., and Kosten T.R. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 87 (2007) 1-9
9. González G., Severino K., Sofuoglu M., Poling J., Olivito A., Gonsai K., George T.P., and Kosten T.R. Tiagabine increases cocaine (benzoylecgonine) free urines in recently admitted cocaine-dependent methadone treated patients: preliminary results of a randomized clinical trial. Addiction 98 (2003) 1625-1632
10. Kang S.Y., Kleinman P.H., Woody G.E., Millman R.B., Todd T.C., Kemp J., and Lipton D.S. Outcomes for cocaine abusers after once-a-week psychosocial therapy. Am. J. Psychiatry 148 (1991) 630-635
11. Koob G.F., and Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9 (1997) 482-497
12. Kushner S.A., Dewey S.L., and Kornetsky C. Comparison of the effects of vagabatrin on cocaine self-administration and food reinforcement. Soc. Neurosci. (1997) 1942 (Meeting Abstracts)
13. Kushner S.A., Dewey S.L., and Kornetsky C. The effects of gamma-vinyl GABA on cocaine-induced lowering of brain-stimulation reward thresholds. Pychopharmacology 133 (1997) 383-388
14. Leach J.P., Sills G.J., Butler E., Forrest G., Thompson G.G., and Brodie M.J. Neurochemical actions of vigabatrin and tiagabine alone and in combination in mouse cortex. Gen. Pharmacol. 28 (1997) 715-719
15. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 9 (1992) 199-213
16. Mezinskis J., Dryenforth S., Goldsmith R., Cohen R., and Somoza E. Craving and withdrawal symptoms for various drugs of abuse. Psychiatr. Ann. 28 (1998) 577-583
17. Morgan A.E., and Dewey S.L. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28 (1998) 60-65
18. Preston K.L., Silverman K., Schuster C.R., and Cone E.J. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 92 (1997) 717-727
19. SAS Institute Inc. SAS/STAT software, Version 9.1 of the SAS System for Microsoft Windows. Copyright © (2002-2003), Cary, NC, USA: SAS Institute Inc.
20. Sobell L.C., and Sobell M.B. Timeline follow back: a technique for assessing self-reported ethanol consumption. In: Allen J., and Lit-ten R. (Eds). Techniques to Assess Alcohol Consumption (1992), Humana Press, Inc, New Jersey 19-28
21. Schachter S.C. Tiagabine monotherapy in the treatment of partial epilepsy. Epilepsia 36 Suppl. 6 (1995) S2-S6
22. Thisted R.A. Elements of Statistical Computing (1988), Chapman and Hall, New York
23. Tracy K., Baker S., LoCastro J., Mezinskis J., Simon S., and Somoza E. The Substance Clinical Global Impression (SCGI) Scale: measuring global functioning in substance related clinical trials. NIDA Res Mon (2000) 180
24. Vocci F.J., Acri J., and Elkashef A. Medication development for addictive disorders: the state of the science. Am. J. Psychiatry 162 (2005) 1432-1440
25. Winhusen T., Somoza E., Harrer J., Mezinskis J., Montgomery M., Goldsmith R., Coleman F., Bloch D., Leiderman D., Singal B., Berger P., and Elkashef A. A placebo-controlled screening trial of tiagabine, sertraline, and donepezil as cocaine dependence treatments. Addiction 100 Suppl. 1 (2005) 68-77